sciencenewsnet.in

Food-Drug Interactions Could be Impactful for Some Lung Cancer Patients According to New Study in JNCCN

June 12, 2023 sarah JonasResearch Results

New research in the June 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that when alectinib—a safe and effective small molecule kinase inhibitor used to treat some types of advanced lung cancer—was taken with a fuller breakfast, or with lunch, it resulted in significantly higher drug concentrations than when taken with a low-fat breakfast.

Researchers demonstrate in mice a new way to deliver medication to malignant brain tumors

November 17, 2022 sarah JonasResearch Results

Researchers have demonstrated in mice a new approach for delivering medication across the blood-brain barrier to treat tumors that cause aggressive, lethal brain cancer.

There’s a Better Way to Detect High-Risk Medications in Older Adults with Cancer According to New Study in JNCCN

August 10, 2022 sarah JonasResearch Results

Gerontology researchers teamed up with hematologic-oncology investigators from Brigham and Women’s Hospital and the Dana-Farber Cancer Institute to look at the association between older patients with blood cancers who were taking multiple medications and their corresponding frailty. They also created a new scale based on a list of Potentially Inappropriate Medications (PIMs) from the NCCN Guidelines® for Older Adult Oncology—called the Geriatric Oncology-Potentially Inappropriate Medications (GO-PIMs) Scale—and found it to be more effective at predicting frailty than conventional methods.